Calpain 9 as a therapeutic target in TGFβ-induced mesenchymal transition and fibrosis
David H. Kim(University of Maryland, Baltimore), Harry C. Dietz(Johns Hopkins University), Elena Gallo MacFarlane(Johns Hopkins University), Wayne Mitzner(Johns Hopkins University), Daniel Warren(Johns Hopkins University), Russell A. Gould(Cornell University), Rosanne Rouf(Johns Hopkins University), Tyler J. Creamer(Johns Hopkins University), James D. Beckett(Johns Hopkins University), Manuel Alejandro Seman-Senderos(University of Maryland, Baltimore), Varun Nagpal(Johns Hopkins University), Yi‐Chun Chen(Johns Hopkins University), Jonathan T. Butcher(Cornell University), Shoji Hata(Tokyo Metropolitan Institute of Medical Science), Djahida Bedja(Johns Hopkins University)
Cited by 38
Related Papers
A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2
|Nature Genetics|2005|1.8k
Angiotensin II Blockade and Aortic-Root Dilation in Marfan's Syndrome
|New England Journal of Medicine|2008|839
Multimodality Imaging of Diseases of the Thoracic Aorta in Adults: From the American Society of Echocardiography and the European Association of Cardiovascular Imaging
|Journal of the American Society of Echocardiography|2015|624
TGF-β–dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome
|Journal of Clinical Investigation|2004|519
TGF-β–dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome
|Journal of Clinical Investigation|2004|478